- Home
- GSUN vs ONCO Comparison
GSUN vs ONCO Comparison
Compare GSUN & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- ONCO
- Stock Information
- Founded
- GSUN 1997
- ONCO 2018
- Country
- GSUN China
- ONCO United States
- Employees
- GSUN N/A
- ONCO N/A
- Industry
- GSUN Other Consumer Services
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- GSUN Real Estate
- ONCO Health Care
- Exchange
- GSUN Nasdaq
- ONCO Nasdaq
- Market Cap
- GSUN 5.4M
- ONCO 3.3M
- IPO Year
- GSUN 2022
- ONCO 2022
- Fundamental
- Price
- GSUN $2.95
- ONCO $0.35
- Analyst Decision
- GSUN
- ONCO
- Analyst Count
- GSUN 0
- ONCO 0
- Target Price
- GSUN N/A
- ONCO N/A
- AVG Volume (30 Days)
- GSUN 14.8K
- ONCO 477.1K
- Earning Date
- GSUN 02-05-2025
- ONCO 12-10-2024
- Dividend Yield
- GSUN N/A
- ONCO N/A
- EPS Growth
- GSUN N/A
- ONCO N/A
- EPS
- GSUN N/A
- ONCO N/A
- Revenue
- GSUN $6,336,931.00
- ONCO $1,870,605.00
- Revenue This Year
- GSUN N/A
- ONCO N/A
- Revenue Next Year
- GSUN N/A
- ONCO N/A
- P/E Ratio
- GSUN N/A
- ONCO N/A
- Revenue Growth
- GSUN N/A
- ONCO N/A
- 52 Week Low
- GSUN $2.21
- ONCO $0.32
- 52 Week High
- GSUN $11.20
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- GSUN 50.51
- ONCO 21.83
- Support Level
- GSUN $2.74
- ONCO $0.33
- Resistance Level
- GSUN $2.80
- ONCO $0.40
- Average True Range (ATR)
- GSUN 0.13
- ONCO 0.07
- MACD
- GSUN 0.03
- ONCO 0.09
- Stochastic Oscillator
- GSUN 56.06
- ONCO 8.03
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is engaged in the provision of education and management services in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistic and consulting services. The company operates in two segments; Education segment and the Wellness segment. Majority of the revenue is generated from the Education segment which offers foreign language tutorial services and other education training management services in China. The wellness segment offers wellness service and related products.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.